Royalty Pharma
RPRX · NASDAQ
Bulios Fair Price
$37.93
33.1% downside
Current Price
$56.66
According to Bulios Fair Price, RPRX is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
About the company
Royalty Pharma plc is an international pharmaceutical company based in New York, USA, specializing in investments in royalty and licensing rights to pharmaceutical products. The company focuses on providing financial resources to research and development pharmaceutical companies in exchange for rights to profits from the sale of their drugs.
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Pablo Legorreta
Employees
100
Headquarters
New York
Upcoming events
Earnings
Upcoming earnings report